Washington editor Jill Wechsler provides an updated list of U.S. regulatory agency personnel.
Director
Bernard Schwetz (240) 453-6900
NIH Institutes, Center, and Divisions
Deputy Director and Director, Office of International Activities
Melody Lin (240) 453-8126
Associate Director, Regulatory Affairs
Michael Carome (240) 453-8237
Director, Division of Compliance Oversight
Kristina Borror (240) 453-8132
Director, Division of Education and Development
Shirley Hicks (240) 453-8227
Director, Division of Policy and Assurances
Irene Stith-Coleman (240) 453-8138
Commissioner
Andrew von Eschenbach* (301) 827-3310
Deputy Commissioner for Operations
Janet Woodcock (301) 827-3310
Deputy Commissioner for Policy
Scott Gottlieb (301) 827-9776
Deputy Commissioner for International and Special Programs
Murray Lumpkin (301) 827-5709
Chief Staff Officer and Associate Commissioner for Legislation
Patrick Ronan (301) 827-0087
Chief Counsel
Sheldon Bradshaw (301) 827-1137
Senior Associate Commissioner for Policy, Planning
Randall Lutter (301) 827-5292
Associate Commissioner for Science and Health Coordination
Norris Alderson (301) 827-3340
Assistant Commissioner for Science and Deputy Director, Office of Science & Health Coordination
Linda Tollefson (301) 827-3340
Associate Commissioner for External Relations
Jason Brodsky (301) 827-6251
Associate Commissioner for Planning
Theresa Mullin (301) 827-5292
Associate Commissioner for Management and Chief Financial Officer
Kathleen Heuer (301) 255-6762
Assistant Commissioner for Policy
Jeffrey Shuren (301) 827-3360
Assistant Commissioner for Counterterrorism Policy
Boris Lushniak (301) 827-4067
Assistant Commissioner for International Programs
Melinda Plaisier (301) 827-4480
Assistant Commissioner for Women's Health
Kathleen Uhl (301) 827-0350
Director, Office of Crisis Management
Ellen Morrison (301) 827-5660
Director, Office of Combination Products
Mark Kramer (301) 427-1934
Director, Office of Orphan Products Development
Marlene Haffner (301) 827-3666
Director, Office of Pediatric Therapeutics
Dianne Murphy (301) 827-9218
Director, Office of Special Health Issues
Theresa Toigo (301) 827-4460
Senior Advisor for Clinical Science
David Lepay (301) 827-3340
Special Assistant to the Director
Patricia Beers Block (301) 827-3340
Associate Director for Human Subject Protection Policy
Bonnie Lee (301) 827-3340
Expert Consumer Safety Officer
Carolyn Hommel (301) 827-3340
Biophysicist
Jean Toth-Allen (301) 827-3340
Associate Commissioner for Regulatory Affairs
Margaret Glavin (301) 827-3101
Deputy Commissioner for Compliance Policy
David Horowitz (301) 827-3101
Deputy Commissioner for Field Operations
Diana Kolaitis (718) 662-5416
Senior Advisor for Clinical Science
Lori Love (301) 827-3684
Director
Daniel Schultz (240) 276-3139
Deputy Director
Linda Kahan (240) 276-3139
Director, Office of Device Evaluation
Donna Bea Tillman (240) 276-3993
Director, Office of Compliance
Timothy Ulatowski (301) 276-0100
Director, Division of Bioresearch Monitoring
Michael Marcarelli (301) 276-0125
Director, Office of In Vitro Diagnostic Device Evaluation and Safety
Steven Gutman (240) 276-0484
Director, Office of Surveillance and Biometrics
Susan Gardner (240) 276-3351
Director
Steven Galson (301) 594-5400
Deputy Director
Douglas Throckmorton (301) 594-5400
Associate Director for Safety Policy and Communications
Paul Seligman (301) 443-5620
Drug Safety Oversight Board
Susan Cummins (301) 443-5284
Associate Director for Medical Informatics
Randy Levin (301) 827-7784
Associate Director for Regulatory Policy
Jane Axelrad (301) 594-5400
Director, Office of Executive Programs
Jane Ware* (301) 443-5293
Director, Office of Management
Russell Abbott (301) 594-6741
Director, Office of Training and Communication
Nancy Smith (301) 827-1651
Director, Office of Information Technology
James Shugars (301) 827-6240
Director, Office of Counter-Terrorism and Pediatric Drug Development
Rosemary Roberts (301) 796-7210
Director
Shirley Murphy (301) 796-2600
Director, Office of Clinical Pharmacology and Biopharmaceutics
Lawrence Lesko (301) 796-2450
Director, Office of Biostatistics
Robert O'Neill (301) 827-3195
Director
Deborah Autor (301) 827-8910
Deputy Director
Joe Famulare* (301) 827-8910
Director, Division of Scientific Investigations
Joseph Salewski (301) 594-0020
Chief, Good Clinical Practices Branch I
Ni Khin (301) 827-7395
Chief, Good Clinical Practices Branch II
Leslie Ball (301) 827-5455
Chief, GLP/Bioequivalence Investigations Branch
C.T. Viswanathan (301) 594-0163
Director
Robert Temple (301) 796-2270
Deputy Director
Rachel Behrman (301) 796-2270
Director, Division of Drug Marketing, Advertising, and Communications
Thomas Abrams (301) 796-1200
Director
John Jenkins (301) 796-0700
Deputy Director
Sandra Kweder (301) 796-0700
Director, Office of Drug Evaluation I
Robert Temple* (301) 796-2270
Director, Office of Drug Evaluation II
Robert Meyer (301) 796-2310
Director, Office of Drug Evaluation III
Julie Beitz (301) 796-0848
Director, Office of Antimicrobial Products
Mark Goldberger (301) 796-0720
Director, Office of Oncology Products
Richard Pazdur (301) 796-2340
Director, Office of Nonprescription Products
Charles Gamley (301) 796-2060
Director
Helen Winkle (301) 796-2400
Deputy Director
Keith Webber (301) 796-2400
Director, Office of New Drug Quality Assessment
Moheb Nasr (301) 796-1900
Director, Office of Generic Drugs
Gary Buehler (240) 276-9310
Director, Office of Testing and Research
Linda Bushe (314) 529-2134
Director, Office of Biotechnology Products
Steven Kozlowski (301) 796-2390
Director
Gerald Dal Pan (301) 796-2380
Director
Jesse Goodman (301) 827-0372
Deputy Director, Medical
Karen Midthun (301) 827-0376
Associate Director for Policy
Diane Maloney (301) 827-0372
Associate Director for Research
Kathryn Carbone (301) 827-0377
Associate Director for Quality Assurance
Sheryl Lard-Whiteford (301) 827-0379
Associate Director for Review Management
Robert Yetter (301) 827-0373
Senior Policy Advisor and Counselor for Biologics
Jill Warner (301) 827-0372
Director, Office of Biostatistics and Epidemiology
Mary Foulkes (301) 827-3034
Director, Office of Communication, Training, and Manufacturers Assistance
Dennis Strickland* (301) 827-2000
Director, Office of Management
Joseph Biviano (301) 827-1320
Director, Office of Information Technology
Ginger Leo* (301) 827-1368
Director, Office of Blood Research and Review
Jay Epstein (301) 827-3518
Director, Office of Vaccines Research and Review
Norman Baylor (301) 827-0655
Director, Office of Cellular, Tissue, and Gene Therapies
Celia Witten (301) 827-6536
Director, Office of Compliance and Biologics Quality
Mary Anne Malarkey (301) 827-6190
Director, Division of Inspections and Surveillance
Gilliam Conley (301) 827-6220
Chief, Bioresearch Monitoring Branch
Patricia Holobaugh (301) 827-6220
*Acting
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.